Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
09/1995
09/06/1995EP0669925A1 Aids therapeutics based on hiv ma peptides
09/06/1995EP0669897A1 Separation of nucleic acid fragments
09/06/1995EP0669829A1 Enhancement of xenograft tolerance and porcine cytokines therefor
09/05/1995US5447959 Vitamin A derivatives
09/05/1995US5447848 Detection of campylobacter with nucleic acid probes
09/05/1995US5447692 Automatic chemical reactors and reservoirs for controlling delivery and bubbling
08/1995
08/31/1995WO1995023223A1 Dna encoding the vertebrate homolog of hedgehog, vhh-1, expressed by the notochord, and uses thereof
08/31/1995WO1995023216A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
08/31/1995WO1995023162A1 Modified oligonucleotide duplexes having anticancer activity
08/31/1995WO1995023161A1 Growth arrest homeobox gene
08/31/1995WO1995023160A1 Novel phosphoramidate and phophorothioamidate oligomeric compounds
08/31/1995WO1995023159A1 Novel bombesin-related peptides
08/31/1995WO1995022988A1 Vacuolating toxin-deficient h. pylori and related methods
08/31/1995WO1995022980A1 Inhibin compositions and methods of use thereof
08/31/1995WO1995016036A3 IFN-ηRECEPTOR β-CHAIN AND DERIVATIVES THEREOF
08/31/1995DE4406073A1 Verfahren zur Herstellung von humanen, klonogenen Fibroblasten, Verfahren zur Gentransfizierung von Fibroblasten und so erhaltene Fibroblasten A process for the production of human, clonogenic fibroblasts method for Gentransfizierung of fibroblasts and fibroblasts thus obtained
08/31/1995CA2468048A1 Process for purifying chemically synthesized rna
08/31/1995CA2184092A1 Dna encoding the vertebrate homolog of hedgehog, vhh-1, expressed by the notochord, and uses thereof
08/31/1995CA2183863A1 Growth arrest homeobox gene
08/31/1995CA2183769A1 Vacuolating toxin-deficient h. pylori and related methods
08/31/1995CA2183556A1 Novel bombesin-related peptides
08/31/1995CA2183438A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
08/30/1995EP0669402A2 Nucleic acid sequences specific for mycobacterium kansasii
08/30/1995EP0669401A2 Amplification of long nucleic acid sequences by PCR
08/30/1995EP0669400A1 Method of diagnosing cancer or precancerous state by analysis of IRF-1-specific RNA
08/30/1995EP0668932A1 Positional sequencing by hybridization
08/30/1995EP0668931A1 Nucleic acid ligands and methods for producing the same
08/30/1995EP0668919A1 Genes for microsomal delta-12 fatty acid desaturases and related enzymes from plants
08/30/1995EP0668777A1 Prostate-specific membrane antigen
08/30/1995EP0668771A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs
08/29/1995US5446137 Substituent selected from linking group containing modifiers such as biotin, reactive groups, nucleic acids, catalysts, DNA intercalators, minor groove binders, clevage agents, and detectable labels
08/29/1995US5445935 Quantitative detection of macromolecules with fluorescent oligonucleotides
08/29/1995US5445934 Selective photoremovable groups on surface
08/29/1995US5445933 Strand displacement assay and complex useful therefor
08/26/1995CA2143229A1 Amplification of long nucleic acid sequences by pcr
08/25/1995CA2143261A1 Method of diagnosing cancer, precancerous state, or susceptibility to other forms of diseases by analysis of irf-1-specific rna in biopsy samples
08/24/1995WO1995022619A1 B7-1-specific ligands, and their use for the induction of t cell anergy
08/24/1995WO1995022617A1 Host-vector system for use in gene therapy
08/24/1995WO1995022611A2 Methods and compositions for stimulating bone cells
08/24/1995WO1995022608A1 Galanin receptor, nucleic acids, transformed cells and uses thereof
08/24/1995WO1995022604A1 Rna editing enzyme and methods of use thereof
08/24/1995WO1995022554A1 Oligonucleotides with anti-epstein-barr virus activity
08/24/1995WO1995022553A1 Oligonucleotides with anti-respiratory syncytial virus activity
08/24/1995WO1995022340A1 Methods for altering fertility
08/24/1995CA2183680A1 B7-1-specific ligands, and their use for the induction of t cell anergy
08/24/1995CA2183253A1 Rna editing enzyme and methods of use thereof
08/24/1995CA2181546A1 Oligonucleotides with anti-respiratory syncytial virus activity
08/23/1995EP0668351A1 Erythropoietin isoforms
08/23/1995EP0667920A1 Methods of detecting micrometastasis of prostate cancer
08/23/1995EP0667919A1 Improved electrochemiluminescent label for dna probe assays
08/23/1995EP0667901A1 Novel cytokine
08/23/1995EP0667870A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b)
08/23/1995EP0667869A1 Assay for inhibitors of farnesyl-protein transferase
08/23/1995EP0667792A1 Specific tolerance in transplantation
08/23/1995EP0667778A1 Treatment of melanoma with antisense oligonucleotides to c-myb proto-oncogene
08/22/1995US5444151 Platelet derived growth factor antagonists
08/22/1995US5444053 Method for treating symptoms of Alzheimer's with NADH and NADPH
08/22/1995US5443953 Genetic engineering; diagnosis, therapy
08/22/1995US5443827 Chimeric molecule; anticoagulants
08/17/1995WO1995021931A1 Nucleic acid-containing composition, its preparation and use
08/17/1995WO1995021927A2 Targeting gene therapy
08/17/1995WO1995021926A1 Inducing tolerance with tolerogenic fusion proteins
08/17/1995WO1995021920A1 Hematopoietic protein and materials and methods for making it
08/17/1995WO1995021917A1 Mammalian cell cycle protein
08/17/1995WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995WO1995021912A1 Non-pathogenic strains of hiv-1
08/17/1995WO1995021868A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995WO1995021853A1 High-affinity ligands of basic fibroblast growth factor and thrombin
08/17/1995WO1995021849A1 Process for separating double-stranded/single-stranded nucleic acid structures
08/17/1995WO1995021845A1 Texaphyrin metal complexes having improved functionalization
08/17/1995WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
08/17/1995WO1995021528A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
08/17/1995WO1995007994A3 Recombinant alphavirus vectors
08/17/1995DE4420782C1 New DNA encoding a 2-oxoglutarate-malate translocator
08/17/1995CA2185683A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995CA2183266A1 Hematopoietic protein and materials and methods for making it
08/17/1995CA2183254A1 Mammalian cell cycle protein
08/17/1995CA2183154A1 Non-pathogenic strains of hiv-1
08/17/1995CA2183066A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995CA2182977A1 Inducing tolerance with tolerogenic fusion proteins
08/17/1995CA2182960A1 Texaphyrin metal complexes having improved functionalization
08/17/1995CA2182118A1 Nucleic acid-containing composition, its preparation and use
08/16/1995EP0667397A1 Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof
08/16/1995EP0666929A1 Method of inhibiting replication of hyperproliferative cells
08/16/1995EP0666926A1 Nuclear hormone receptor-interacting polypeptides and related molecules and methods
08/16/1995EP0666923A1 Targeted delivery of poly- or oligonucleotides to cells
08/16/1995EP0666920A1 Thrombin activatable plasminogen derivatives
08/16/1995EP0666919A1 Vaccine containing a thiol protease
08/16/1995EP0666918A1 PRODUCTION OF GAMMA LINOLENIC ACID BY A $g(D)6-DESATURASE
08/16/1995EP0666914A1 Novel p-selectin ligand protein
08/16/1995EP0666910A1 Method of cleaving specific strands of rna
08/16/1995EP0666865A1 Plant fatty acid synthases
08/16/1995EP0666864A1 Polymorphic locus
08/16/1995EP0289619B1 Process for synthesizing oligonucleotides and compounds for forming high-molecular protective group
08/15/1995US5441868 Production of recombinant erythropoietin
08/15/1995CA1336685C Diagnosing and treating viral infections associated with chronic fatigue
08/15/1995CA1336684C Dsrna-based prevention of viral escape
08/15/1995CA1336683C Diagnosis and treatment of double-stranded rna deficiency states
08/10/1995WO1995021265A1 Methods for discovering ligands
08/10/1995WO1995021256A1 Msrv1 virus and msrv2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same